Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS

被引:47
作者
Sgagias, MK
Wagner, KU
Hamik, B
Stoeger, S
Spieker, R
Huber, LJ
Chodosh, LA
Cowan, KH
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[2] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
Bcra1-deficiency; DNA-damage and repair; breast cancer; CDDP; MMS;
D O I
10.4161/cc.3.11.1211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock-out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(f1/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1-/- MMECs were generated by deletion of exon 11 following transduction of Brca1(f1/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride ( CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECs is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays a role in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 48 条
  • [1] BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
    Abbott, DW
    Thompson, ME
    Robinson-Benion, C
    Tomlinson, G
    Jensen, RA
    Holt, JT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18808 - 18812
  • [2] MOUSE BRCA1 - LOCALIZATION, SEQUENCE-ANALYSIS AND IDENTIFICATION OF EVOLUTIONARILY CONSERVED DOMAINS
    ABEL, KJ
    XU, JZ
    YIN, GY
    LYONS, RH
    MEISLER, MH
    WEBER, BL
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (12) : 2265 - 2273
  • [3] Aida H, 1998, CLIN CANCER RES, V4, P235
  • [4] A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
    Antoniou, AC
    Pharoah, PDP
    McMullan, G
    Day, NE
    Stratton, MR
    Peto, J
    Ponder, BJ
    Easton, DF
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (01) : 76 - 83
  • [5] Sequence analysis of the rat Brca1 homolog and its promoter region
    Bennett, LM
    Brownlee, HA
    Hagavik, S
    Wiseman, RW
    [J]. MAMMALIAN GENOME, 1999, 10 (01) : 19 - 25
  • [6] The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
    Bhattacharyya, A
    Ear, US
    Koller, BH
    Weichselbaum, RR
    Bishop, DK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 23899 - 23903
  • [7] Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism
    Cavalieri, EL
    Rogan, EG
    Chakravarti, D
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (04) : 665 - 681
  • [8] Chandler J, 2001, GENESIS, V29, P72, DOI 10.1002/1526-968X(200102)29:2<72::AID-GENE1007>3.0.CO
  • [9] 2-B
  • [10] Relationship between base excision repair capacity and DNA alkylating agent sensitivity in mouse monocytes
    Chen, KH
    Srivastava, DK
    Wilson, SH
    [J]. MUTATION RESEARCH-DNA REPAIR, 2001, 487 (3-4): : 121 - 126